The development of autoimmune hepatitis and primary biliary cirrhosis overlap syndrome during the course of connective tissue diseases: report of three cases and review of the literature.
Efe
Cumali
C
Department of Gastroenterology, Numune Education and Training Hospital, Ankara, Turkey. drcumi21@hotmail.com
Ozaslan
Ersan
E
Nasiroglu
Narin
N
Tunca
Hasan
H
Purnak
Tugrul
T
Altiparmak
Emin
E
D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors; D002756:Cholagogues and Choleretics / Q000627:therapeutic use; D015209:Cholangitis, Sclerosing / Q000150:complications* / Q000188:drug therapy; D005260:Female; D019693:Hepatitis, Autoimmune / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008105:Liver Cirrhosis, Biliary / Q000150:complications* / Q000188:drug therapy; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy; D008875:Middle Aged; D012595:Scleroderma, Systemic / Q000150:complications* / Q000188:drug therapy; D012859:Sjogren's Syndrome / Q000150:complications* / Q000188:drug therapy; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D002756:Cholagogues and Choleretics; D007166:Immunosuppressive Agents; D014580:Ursodeoxycholic Acid